163 related articles for article (PubMed ID: 27057672)
1. Synergistic effects of resveratrol (free and inclusion complex) and sulfamethoxazole-trimetropim treatment on pathology, oxidant/antioxidant status and behavior of mice infected with Toxoplasma gondii.
Bottari NB; Baldissera MD; Tonin AA; Rech VC; Alves CB; D'Avila F; Thomé GR; Guarda NS; Moresco RN; Camillo G; Vogel FF; Luchese C; Schetinger MRC; Morsch VM; Tochetto C; Fighera R; Nishihira VSK; Da Silva AS
Microb Pathog; 2016 Jun; 95():166-174. PubMed ID: 27057672
[TBL] [Abstract][Full Text] [Related]
2. Sulfamethoxazole-trimethoprim associated with resveratrol for the treatment of toxoplasmosis in mice: Influence on the activity of enzymes involved in brain neurotransmission.
Bottari NB; Baldissera MD; Tonin AA; Rech VC; Nishihira VS; Thomé GR; Schetinger MR; Morsch VM; Camillo G; Vogel FF; Tochetto C; Fighera R; Machado G; Stefani LM; Da Silva AS
Microb Pathog; 2015 Feb; 79():17-23. PubMed ID: 25572158
[TBL] [Abstract][Full Text] [Related]
3. Effects of sulfamethoxazole-trimethoprim associated to resveratrol on its free form and complexed with 2-hydroxypropyl-β-cyclodextrin on cytokines levels of mice infected by Toxoplasma gondii.
Bottari NB; Baldissera MD; Tonin AA; Rech VC; Nishihira VS; Thomé GR; Camillo G; Vogel FF; Duarte MM; Schetinger MR; Morsch VM; Tochetto C; Fighera R; Da Silva AS
Microb Pathog; 2015 Oct; 87():40-4. PubMed ID: 26209515
[TBL] [Abstract][Full Text] [Related]
4. Diphenyl diselenide supplementation in infected mice by Toxoplasma gondii: Protective effect on behavior, neuromodulation and oxidative stress caused by disease.
Machado VS; Bottari NB; Baldissera MD; Rech VC; Ianiski FR; Signor C; Rubin MA; Waczuk EP; Schwertz CI; Mendes RE; Camillo G; Vogel FF; de la Rue ML; Morsch VM; Schetinger MR; Frühauf PK; Da Silva AS
Exp Parasitol; 2016 Oct; 169():51-8. PubMed ID: 27472985
[TBL] [Abstract][Full Text] [Related]
5. Toxoplasma gondii: Effects of diphenyl diselenide in experimental toxoplasmosis on biomarkers of cardiac function.
Machado VS; Bottari NB; Baldissera MD; Isabel de Azevedo M; Rech VC; Ianiski FR; Vaucher RA; Mendes RE; Camillo G; Vogel FF; de la Rue ML; Carmo GM; Tonin AA; Da Silva AS
Exp Parasitol; 2016 Aug; 167():25-31. PubMed ID: 27107930
[TBL] [Abstract][Full Text] [Related]
6. Neuroprotective role of resveratrol mediated by purinergic signalling in cerebral cortex of mice infected by Toxoplasma gondii.
Bottari NB; Reichert KP; Fracasso M; Dutra A; Assmann CE; Ulrich H; Schetinger MRC; Morsch VM; Da Silva AS
Parasitol Res; 2020 Sep; 119(9):2897-2905. PubMed ID: 32677001
[TBL] [Abstract][Full Text] [Related]
7. Neurotoxicity and immunotoxicity assessment in CBA/J mice with chronic Toxoplasma gondii infection and single-dose exposure to methylmercury.
King MD; Lindsay DS; Holladay S; Ehrich M
Int J Toxicol; 2003; 22(1):53-61. PubMed ID: 12573950
[TBL] [Abstract][Full Text] [Related]
8. Comparative effects of cotrimoxazole (trimethoprim-sulphamethoxazole), pyrimethamine-sulphadiazine and spiramycin during avirulent infection with Toxoplasma gondii (Beverley strain) in mice.
Nguyen BT; Stadtsbaeder S
Br J Pharmacol; 1983 Aug; 79(4):923-8. PubMed ID: 6606459
[TBL] [Abstract][Full Text] [Related]
9. [Histopathology changes in mice infected with Toxoplasma gondii Prugniaud strain].
Wu SW; Bao HE; Li XY; Ge S
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2011 Oct; 29(5):327-32. PubMed ID: 24830191
[TBL] [Abstract][Full Text] [Related]
10. Influence of toxoplasmosis on acetylcholinesterase activity, nitric oxide levels and cellular lesion on the brain of mice.
Tonin AA; Da Silva AS; Thomé GR; Sangoi MB; Oliveira LS; Flores MM; Schetinger MR; Fighera RA; Moresco RN; Camillo G; Vogel FS; Lopes ST
Pathol Res Pract; 2014 Aug; 210(8):526-32. PubMed ID: 24951243
[TBL] [Abstract][Full Text] [Related]
11. Toxoplasmosis treatment with diphenyl diselenide in infected mice modulates the activity of purinergic enzymes and reduces inflammation in spleen.
Doleski PH; Ten Caten MV; Passos DF; Castilhos LG; Leal DBR; Machado VS; Bottari NB; Vogel FF; Mendes RE; da Silva AS
Exp Parasitol; 2017 Oct; 181():7-13. PubMed ID: 28710007
[TBL] [Abstract][Full Text] [Related]
12. Behavioral evaluation of BALB/c (Mus musculus) mice infected with genetically distinct strains of Toxoplasma gondii.
Bezerra ECM; Dos Santos SV; Dos Santos TCC; de Andrade HF; Meireles LR
Microb Pathog; 2019 Jan; 126():279-286. PubMed ID: 30447421
[TBL] [Abstract][Full Text] [Related]
13. The effect of trimethoprim and sulfamethoxazole on Toxoplasma gondii in vitro and in vivo.
Grossman PL; Remington JS
Am J Trop Med Hyg; 1979 May; 28(3):445-55. PubMed ID: 453442
[TBL] [Abstract][Full Text] [Related]
14. Neospora caninum and Toxoplasma gondii: relationship between hepatic lesions, cytological and biochemical analysis of the cavitary liquid during the acute phase of the diseases in experimental models.
Bottari NB; Tonin AA; Fighera R; Flores MM; França RT; Camillo G; Toscan G; Vogel FS; Sangoi MB; Bochi GV; Moresco RN; Lopes ST; Da Silva AS
Exp Parasitol; 2014 Jan; 136():68-73. PubMed ID: 24275558
[TBL] [Abstract][Full Text] [Related]
15. Relationship between butyrylcholinesterase activity and liver injury in mice acute infected with Toxoplasma gondii.
Da Silva AS; Tonin AA; Thorstenberg ML; Leal DB; Fighera R; Flores MM; França RT; Camillo G; Vogel FS; de la Rue M; Lopes ST
Pathol Res Pract; 2013 Feb; 209(2):95-8. PubMed ID: 23313104
[TBL] [Abstract][Full Text] [Related]
16. Experimental evaluation of roxithromycin combined with dapsone or sulphamethoxazole on Pneumocystis carinii and Toxoplasma gondii dual infections in a rat model.
Brun-Pascaud M; Chau F; Derouin F; Girard PM
J Antimicrob Chemother; 1998 Mar; 41 Suppl B():57-62. PubMed ID: 9579714
[TBL] [Abstract][Full Text] [Related]
17. [PCR in evaluating the effect of allicin and its combination with SMZco on murine toxoplamosis].
Shan LY; Yang XZ; Liu PM
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2003; 21(4):203-6. PubMed ID: 14628365
[TBL] [Abstract][Full Text] [Related]
18. The synergetic potential of Lactobacillus delbrueckii and Lactobacillus fermentum probiotics in alleviating the outcome of acute toxoplasmosis in mice.
Almallah TM; Khedr SI; El Nouby KA; Younis SS; Elazeem MA; Elmehy DA
Parasitol Res; 2023 Apr; 122(4):927-937. PubMed ID: 36786888
[TBL] [Abstract][Full Text] [Related]
19. Activity of epiroprim (Ro 11-8958), a dihydrofolate reductase inhibitor, alone and in combination with dapsone against Toxoplasma gondii.
Chang HR; Arsenijevic D; Comte R; Polak A; Then RL; Pechère JC
Antimicrob Agents Chemother; 1994 Aug; 38(8):1803-7. PubMed ID: 7986011
[TBL] [Abstract][Full Text] [Related]
20. Enrofloxacin is able to control Toxoplasma gondii infection in both in vitro and in vivo experimental models.
Barbosa BF; Gomes AO; Ferro EA; Napolitano DR; Mineo JR; Silva NM
Vet Parasitol; 2012 Jun; 187(1-2):44-52. PubMed ID: 22281151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
